Clinical Trials on Limited Systemic Sclerosis
Total 189932 results
-
Neuromed IRCCSNot yet recruitingProgressive Multiple SclerosisItaly
-
Joanne Kurtzberg, MDRecruitingPrimary Progressive Multiple SclerosisUnited States
-
SanofiRecruitingPrimary Progressive Multiple SclerosisSpain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more
-
Hoffmann-La RocheRecruitingMultiple Sclerosis, Primary ProgressiveCanada, United States, Spain, Croatia, Serbia, Portugal, France, Tunisia, Mexico, Poland, Russian Federation, Australia, Belgium, Italy, United Kingdom, Ukraine, Bulgaria, Colombia, Georgia, Germany, Romania, New Zealand, Lebanon, Aus... and more
-
Fundació Institut Germans Trias i PujolClinica Universidad de Navarra, Universidad de NavarraRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingSpain
-
Immunic AGActive, not recruitingMultiple SclerosisUnited States, Germany, Netherlands, Bulgaria, Serbia, Canada, Czechia, Moldova, Republic of, North Macedonia, Poland, Romania, Ukraine
-
Turku University HospitalActive, not recruitingMultiple SclerosisFinland
-
Mapi Pharma Ltd.Active, not recruitingPrimary Progressive Multiple SclerosisIsrael, Moldova, Republic of
-
Terry L. WahlsCompleted
-
Kyverna TherapeuticsNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive
-
University of UtahCompletedMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Secondary Progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)Czech Republic, Switzerland
-
Novartis PharmaceuticalsActive, not recruitingActive Secondary Progressive Multiple SclerosisItaly
-
Novartis PharmaceuticalsTerminatedSecondary Progressive Multiple Sclerosis With Inflammatory Disease ActivitySwitzerland
-
Kessler FoundationInternational Progressive MS AllianceCompletedMemory Impairment | Cognition - Other | Multiple Sclerosis, ProgressiveUnited States
-
Andalusian Initiative for Advanced Therapies -...Carlos III Health InstituteCompletedNervous System Diseases | Immune System Diseases | Demyelinating Autoimmune Diseases, CNS | Autoimmune Diseases of the Nervous System | Demyelinating Diseases | Autoimmune DiseasesSpain
-
SanofiRecruitingMultiple SclerosisUnited States, Canada, Australia, Puerto Rico, United Kingdom, Turkey
-
University of CalgaryRecruiting
-
Danish Research Centre for Magnetic ResonanceScleroseforeningen; Danish Multiple Sclerosis CenterRecruitingPrimary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
University of NottinghamNottingham University Hospitals NHS TrustCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
University College, LondonUniversity of Leeds; University of Sheffield; Medical Research Council; Queen Mary... and other collaboratorsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Isfahan University of Medical SciencesCompletedSecondary Progressive Multiple SclerosisIran, Islamic Republic of
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
Merck KGaA, Darmstadt, GermanyMerck Quimica Argentina S.A.I.CCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedSecondary Progressive Multiple SclerosisGermany
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
Bristol-Myers SquibbRecruitingRelapsing Multiple SclerosisChina
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisPortugal
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisGermany
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisUnited Arab Emirates, Oman
-
University Hospital, Basel, SwitzerlandFreie Akademische Gesellschaft BaselRecruitingMultiple Sclerosis (MS)Switzerland
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...EMD Serono Research & Development Institute, Inc.TerminatedRelapsing Multiple SclerosisUnited States, Belarus, Brazil, Bulgaria, Canada, France, Germany, Greece, India, Italy, Latvia, Lithuania, Malaysia, Moldova, Republic of, Norway, Philippines, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Saudi Arabia and more
-
Hoffmann-La RocheCompletedRelapsing Multiple SclerosisUnited States, Spain, Czechia, Belgium, Italy, Canada, United Kingdom, Germany, Ireland, Turkey, Poland, Russian Federation, Ukraine, Croatia, Argentina, France, Belarus, Brazil, Mexico, Bosnia and Herzegovina, Bulgaria, Slovakia, S... and more
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis (MS)United States, Lebanon, Spain, Sweden, Poland, Italy, Estonia, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Czechia, Finland, France, Georgia, Germany, Korea, Republic of, Lithuania, Norway, Portugal, Romania, Russian Federation and more
-
Nermin ÇalışırBursa Sevket Yilmaz Training and Research HospitalActive, not recruitingMS (Multiple Sclerosis)Turkey
-
SanofiActive, not recruitingRelapsing Multiple SclerosisUnited States, Canada, Czechia, Estonia, France, Netherlands, Russian Federation, Spain, Ukraine
-
SanofiCompletedRelapsing Multiple SclerosisFrance, United States, Canada, Czechia, Estonia, Netherlands, Russian Federation, Slovakia, Spain, Ukraine
-
CelgeneCompletedRelapsing Multiple SclerosisSerbia, United States, Poland, Spain, Belgium, Bulgaria, Georgia, Greece, Romania, Russian Federation, Ukraine, Hungary, Italy
-
Fondazione Italiana Sclerosi MultiplaOpera CRO, a TIGERMED Group CompanyUnknownMS (Multiple Sclerosis)Italy, Romania
-
BiogenTerminatedRelapsing Multiple SclerosisUnited States
-
EMD SeronoMerck KGaA, Darmstadt, GermanyTerminatedRelapsing Multiple SclerosisSweden, United States, Czech Republic, Russian Federation, Spain, United Kingdom, Lithuania, Ukraine, Netherlands, Canada, Germany, France, Switzerland, Australia, Belgium, Lebanon, New Caledonia
-
NovartisCompletedRelapsing Multiple SclerosisGermany, Italy, Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, Greece, Hungary, Ireland, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovakia, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
IRCCS Centro Neurolesi "Bonino-Pulejo"CompletedMultiple Sclerosis Relapse
-
Assistance Publique - Hôpitaux de ParisUnknownMultiple Sclerosis (MS)France
-
The University of Texas Health Science Center,...CompletedMultiple Sclerosis (MS)United States
-
Assistance Publique Hopitaux De MarseilleRecruiting